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1, INTRODUCTION 
The src oncogcne product is a phosphoprotcin, 
p60src, with tyrosine kinasc activity [11. Genetic analysis 
has shown that the tyrosinc kinase activity of ~60”” 
plays an essential role in the process of transformation 
121. Membrane association of ~60”” may also bc impor- 
tant for transformation [3], and more recently, the ac- 
tive src gcnc product was shown to be associated with 
the Triton X-100.resistant cytoskeletal structure in 
chicken fibroblasts, while non-transforming SIC pro- 
teins including 1360’-‘~’ were only found in soluble frac- 
tions [S]. Therefore, rather direct contribution of the 
src protein to the cellular cytoskelcton and morphology 
has been suggested. 
Erbstatin has been isolated from Smpfotnyces as an 
inhibitor of tyrosine kinase [6]. It inhibited epidermal 
growth factor (EGF) receptor- and v-src product- 
associated tyrosine kinase in cell culture [71. Recently, it 
was shown to delay the EGF-induced DNA synthesis in 
quiescent normal rat kidney cells without showing ir- 
reversible toxicity [$I. Methyl .2,5-dihydroxycinnamate, 
a stable analogue of erbstatin, showed more prominent 
inhibition of the S-phase induction [8]. In the present 
study we employed these tyrosine kinase inhibitors to 
examine the role of v-src tyrosine kinase in the expres- 
sion of cellular morphology, cytoskeleton and 
Fibronectin. 
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2, MATERIALS AND METIKXS 
Erbslnlin [a], nic~hyl 2,5~tlillytlr~xysifl~i~~~ill~ [HI, and 5’4 
mcthylerbstatin [9] S\IOWII itr Fig. 1 WCPC prcp;\d RI drscribcd before. 
Rat kidney cells IrillNfOrtWX! by ;I leniper;tturc-xcn’siticr: mllYant of 
Hous sarcoma virus (KS+“‘-NRK cells) wcrc kindly supplied by Br M. 
Yoshida, University of Tokyo IlO]; and the lempcreturc-sensitive 
Kirsterr sarcoma virus-infected normal ~PI kidney cells (K-r&‘-NRK 
cells) by Dr T.Y. Shih, Nltl, Wthcsdil \ t I]. A human fibroncc!in 
cDNA clone was isolated from the cDNA library of human breast car- 
cinoma NS578T cells (121; and a &actin gene fragment, pRBAs3’ LII 
[13], w;\s kindly supplied by Dr K. Tokunaga, Chiba Cnnccr Ccntcr 
Research Institute. 
2,2, Ml?1ito1ls 
2,2. I. Cell culture 
RSV’“-NRK cells were cultured in Dulbecco’s modified Eaglc’p 
mcdiunr (DMEM) supplemented with 5% calf serum and antibiotics 
at 33% The cells were inoculalcd at 2x IO~/wcll with I ml medium 
in a t2.well plate, and incubated t or 2 days at 33 or 39°C. Then, 
chemicals were added and after the indicated times cells were 
photographed under a phase-contrast microscope. When erbslatin 
was added, the medium was changed to DMEM containing 20/o calf 
serum. 
2,2.2. Fluorescence staining of aclin filament 
Cells grown on cover glasses were fixed with 3.5% parafor- 
maldehyde in PBS for 20 tnin at room temperature. After a brief rinse 
in PBS, fixed cells were exposed to acetone at - 20°C for 5 min. The 
cover glasses were washed with Ca* * , Mg’* -free PBS and incubated 
with rhodamine-conjugated phailoidin at 37°C for 20 min. Cells thus 
treated were sealed in glycerin buffer and examined by fluorescence 
microscopy (Axiovert: Zeiss). 
2.2.3. Northern blotting 
Total RNA was extracted from sub-confluent monolayers by the 
guanidinc hydrochloride and cesiumchloride method [14]. About 100 
Published ~5.v Elsevier Science Publishers B. V. 
Fig. 2. Induction of morphological change by erbstatin ill RSV’“-NRK cells. RSV”-NRK cells were incubated at 33°C for 8 h without (A) or with 
(Bj 0.6 g~‘ml of erbblatin and photographed under a phase-contrast microscope. 
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Fig, 3. Inhibition of morphological transtormatlon oy croatatm 111 KSV”-NKK cells. Cells were incubated at 39T for2 days (A) and then transfcr- 
red IO a 33°C incubator without (U) or with (C) I pg/ml erbstatin and incubated for a further IS h. 
Fig. 4. Induction of actin stress fibre organization by erbstatin in RSV”-NRK cells. Cells were incubated for 8 h at 39’C (A) or at 33OC without 
(B) or with 0.6 pg/ml of erbstatin (C). 
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Fig. 5, Enhanccmcnt of fibronrctin gene cxprcssion by crbsmin in RSV’*4lRK culls. Cells wcrc incubated at 33°C for I5 h with crbrmin (A) or 
methyl 2,S.dihydrosycinnnmntc (a). ‘lkn, total RNA wnr extracted, nntl an aliquof (IO pg) was elcetrophorcsrd and hybridized with the fibronec- 
tin or /3-ncrin probe. RNA was niso esrractctl from cells cultured al 39°C. The rcsul~s rcprcscnt IWO similnr cxfxrinrents, 
morphological change, Erbstatin at 1 rrg/ml did not 
change the morphology of RSV’“-NRK cells cultured at 
the non-permissive t mperature, and it also had no ef- 
fect on the morphology of temperature-sensitive 
Kirsten sarcoma virus-infected rat kidney cells at the 
permissive temperature. Thus, the morphological effect 
was observed specifically for tyrosine kinase inhibitors, 
and in src-expressing cells. 
By shifting of the temperature from 39’C to 33’C, 
cells can be transformed, The morphological transfor- 
mation was observed within I5 h as shown in Fig. 4B. 
Addition of 1 &ml of erbstatin inhibited this transfor- 
mation, and cells remained flattened, as shown in Fig. 
4C. Methyl 2,5dihydroxycinnamate also inhibited the 
transformation, while 5’-0-methylerbstatin did not 
(data not shown). 
Actin stress fibre organiration was almost completely 
lost in the transformed state in IGWS-NRK cells, while 
it was clearly seen in the normal cell state, as shown in 
Fjg. 5A and B. Addition of 1 &ml erbstatin induced 
stress fibre organization in the cells at 33”C, as shown 
in Fig, SC, although it was not as extcndcd as in Fig. 
5A. 5’-0-methylerbstatin again did not induce the 
cytoskeletal organization. 
Fibronectin gene expression is usually less active in 
transformed cells than in normal cells, and this was 
previously shown to be the case for RSV’S-NRK cells 
[16]. As shown in Fig. 6A and B, erbstatin and methyl 
2,5-dihydroxycinnarnate increased the level of fibronec- 
tin mRNA in transformed RSV’S-NRK cells, while they 
did not change P-actin mRNA expression markedly. 
4. DISCUSSION 
Two related tyrosine kinase inhibitors induced the 
morphological and cytoskeletal change but their inac- 
tive analogue did not. Also, erbstatin showed no effect 
on normal or ras-transformed cells. Therefore, the 
~60~” tyrosine kinase activity is considered to be involv- 
ed in the mechanism of cytoskeletal organization. 
Votuln~, 279, numl~r I FEBS 
Erbstatin inhibits EGF receptor tyrosine kitmsc with  
an lC~o o f  about  0.2 l~$/ml in v i t ro ,  and inh ib i ts  8 rowth  
of RSV~'-NRK cells at about 5 ~/ml  either :it 33~C or 
39'~C. Therefore,  ¢rbstat in  induces normal  phcnotypes 
at lower concentrations than those Showin~, cytotoxici- 
ty. On  the other  hand,  a 1figlter concentrat ion  (12,5 
vs fmi )  was required to inhibit autophosphorylat ion f  
the src protein (data not shown). However, 
autophosphorylat ion may not reflect essential tyrosine 
kinase activities of  the src protein, 
The morpl~olo$ical chan$e induced by erbstatin was 
almost complete within 4 h, which is slightly faster than 
the chanlle induced by the tetrtperature shift. This may 
be because it takes time to inactivate p60 '~' at the non- 
permissive temperature, The morphological effect o f  
erbstatin was reversible even when the chemical was 
present in the medium, probab ly  because of  inactiva- 
tion of' erbstatin. In fact, the inhibitor has been shown 
to be anstable in serum [17]. 
Erbsratin did not induce normal phenotypes in wild 
RSV-NRK or RSV.NIH3T3 cells, Possibly, the p60 '~' 
tyrosine kinase activity would be much higher in these 
cells, and the inhibitors could inhibit it only partially, 
We have also reported that oxanosine induces normal  
phenotypes in K-ras~'-NRK cells, but not in K-ras-NRK 
cells [t'T]. 
Tyrosin¢ kinase inhibitors induced other normal 
phenotypes as well, They increased dze level of 
fibronectin mRNA and adhesion plaques (S. Abe, un. 
published results). Thus, p60 '= tyrosinc kinase activity 
was  shown by the use of specific inhibitors to be involv- 
ed in the expression of transformed phenotypes, 
,,tvkttowledgetneltts: This work was partly supported by grants from 
the Ministry of Science, Education and Cuhure of Japan and by a 
grant from the Foundation for Promotion of Cancer Research 
(Japan), 
LETTERS 
REFERENCES 
Fcbru~try 19ql 
[ I ]  I~rtk~ofl. R.L., Putdbi~. A.I,'., I~rtk~on IL, C'oll~t|, M.~, and 
121 I]tshup, J.M, and Varmt)~. t4, (19~2) in: RNA lumor viruses: 
molecular biololJy of luolor ,~tru~¢~, 2rid td. O,V~t~, R. ¢t M., 
~d~,), pp, 9~9.110~, ¢'~ld Sprin~t Harbor I..mbora~orx, Cold 
Sprlnl~ H~rbor, 
[31 (.'r~, F.R., (lather. I:LA., Pdlmao, I;), and Hanarum. I,I. 
(19~41 Mol. Call, liiol, 4. IMP4-II~42, 
[4] flamal~uchi. M, and lhmaru~m l'l, (19~71 Pro~:. Nad, Acad. Sci, 
USA 84. 2312-2M6. 
1:;) Umcznwa. H., Imolo, M,. Sa~a. T,, h~l~ikl, K,. Mal~uda. N., 
Uchida, T,, linuma. H,. Iotanla(la, M. aml Tak,tu~hi, T. (19~61 
.I, An',tbiot, 39. 17(1=t7}. 
16] hnoto, M,, Umetawa, K. Sawn. T,, Tak~uchi, T. and 
Umc~:iwa, H (19~7) Iliochcm Ira, 15, 9~9-995, 
171 Um¢:cawa, K.. [,*loft. T., '1"~,lj}lll:t, H., hl~oio, M,, ts~hikL K, ~ltl¢| 
"]~akcucht, T, (1990) FI, H:IS Left. 260, 198-200. 
[8) hshiki. K,, 1mote, M,, Takeuclfi, T,, Umexawa, H,, Tsuchida. 
'r,. Yoshioka. T. and 'rat~uza. K. (19a"/} J, Anfibiol. 40, 
1207-1208. 
[gJ Chen, Y,C. Hayman, M.S, a~(I Vo~t, P K, (197`/} Cell II, 
513-~21, 
[10} Shih, T.Y., Weeks, M,O,. YounS, H,A. m~d S~olnick, E.M. 
(19"/91 J. Virol 31, $46-$56, 
[ I I  ] Kornblihu. A.R,, Umezawa. K,, Vibc.Pcdcrscn K. and Barallc, 
F.E, (1985} EMt}O .i, 4, 1755-1"/59. 
[12] Nudel, U,. Zakut, R,. Shani.. M., Neaman. S., Levy, Z. and 
Yaffc, D, (1983) Nucleic Acids Rcs, II. I?~9-I` /71, 
{13} Chirgwin, J.M,, Przybyla, A,E., MacDonald, R.J, :rod Rutter, 
W..I. (19"/91 Biochemistry 18, 5294-5299. 
{14] Maniatis, T., Fritsch, E.F. and Sambrook. J. (1982} in: 
Molecular Cloning, A Laboratory Manual, pp, lS0-172, Cold 
Sprit't~, Harbor Laboratory, Cold St:ring Harbor. 
[15] Umczawa, K.. Atsumi. S.. Matsushima. T, and Takeuchi. T. 
(19871 Experientia 43. 614-616, 
[161 hnoto, M,, Umezawa, K., Komuro, K,, Sawa, T,, Takeachi, T. 
and Umczawa, H. (19B7) .[pn. J. Cancer Rcs. (GamO 78, 
329-332. 
[1"7] ltoh, O,, Kuroiwa, S,, Alsumi, S., Umezawa, K,, Takcucl'fi, T. 
and Hori, M (1989) Cancer Rcs, 49, 996-1000, 
136 
